Indaptus Therapeutics Announces Opening of Next Cohort in Single Dose Ranging Study of Decoy20 Cohort 1 patients exhibited a significant immune response consistent with the mechanism of actionSafety Review Committee approved continuation to the next cohort of patients NEW YORK, Aug. 10,...